Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
biotech
clinical trials
life sciences
national blog main
new york blog main
san francisco blog main
boston blog main
boston top stories
national top stories
new york top stories
san francisco top stories
boston
fda
biotech ipos
multiple myeloma
national
new york
raleigh-durham blog main
raleigh-durham top stories
rare disease drugs
san diego blog main
23andme
acute migrane
acute myeloid leukemia
aligos therapeutics
alx oncology
ancestrydna
antibiotics
artificial intelligence
arvinas
astellas pharma
astrazeneca
atlas venture
audentes therapeutics
autoimmune diseases
avidity biosciences
bain capital
baker brothers life sciences
bausch health
benzodiazepine
What
ipos
6
×
ipo
biotechs
ago
biotech
companies
days
drug
hasn’t
life
medicines
prep
raised
research
science
slowed
way
week
achieve
activity
age
apparently
arrival
billion
catalyst
central
chose
close
cns
combined
company
considering
data
device
diseases
disorder
dog
drugs
dyne
early
Language
unset
Current search:
ipos
×
photo
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@techcrunch.com
4 years ago
All that glitters is not gold: How healthtech startups can achieve true value
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way